Midlothian-based biotechnology company Cytomos has secured £5 million to scale up production of its cell analysis technology.

Cytomos said that the investment will enable it to drive sales of its first commercial product, Celledonia™, built on its cell analysis technology platform, AuraCyt, which is “already generating significant market traction.”

Cytomos has raised £5m to scale up production of its cell analysis technology.

New investment will allow the Edinburgh-based biotechnology company to drive sales of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.

Source: Business Insider